Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-02-24 @ 5:07 AM
Study NCT ID:
NCT03146650
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-18
First Post:
2017-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
Sponsor:
Northwestern University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Major Salivary Gland Carcinoma | View |
| None | Minor Salivary Gland Carcinoma | View |
| None | Recurrent Salivary Gland Carcinoma | View |
| None | Stage IV Major Salivary Gland Carcinoma | View |
| None | Stage IVA Major Salivary Gland Carcinoma | View |
| None | Stage IVB Major Salivary Gland Carcinoma | View |
| None | Stage IVC Major Salivary Gland Carcinoma | View |
Keywords: